Receive Updates in Your Inbox
China Med Device (CMD) provides the regulatory, CRO, and market intelligence to help companies access China’s fast-growing $80-billion MedTech market. CMD has partnered to create over 1,200 success stories for manufacturers of medical devices, IVDs, combination products and more.
U.S. and European companies can be frustrated by China’s National Medical Products Administration (NMPA), a regulatory system that differs greatly from FDA, EU and other international markets. CMD focuses solely on China, so we can help companies overcome regulatory hurdles as well as significant language and cultural differences that can impact your business.
Our team has decades of clinical/technical experience, previously working for MedTech companies or in auditing roles with regulatory agencies. This deeper understanding of medical device development and how NMPA applies requirements in real life allows CMD to deliver clear guidance and practical solutions.
Why Choose CMD
Which Services We Can Support You With
CMD has offices in both Boston and Beijing to give our clients quick access to a local, bilingual and bicultural team. Count on CMD as your partner throughout the complete product life cycle. Here are our key services and areas of expertise:
Clinical Research Organization (CRO)
Business & Commercialization
Follow China Med Device
Connect with CMD for the latest news and guidance: